InterMune (nasdaq)ITMN Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : InterMune (nasdaq)ITMN

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: IRWIN JAMES FRANKEL who wrote (68)	3/15/2001 12:18:38 PM
From: StockMiser	of 508

Well...an even better buy now at 18. I had ITMN at around 12 and sold around 18 (ironic that I buy it again here). Missed the whole run to 55. I think this is the buy op here that everyone will wish they had seen once the stock heads back to 30-40 (stock was 38 only a month ago). No change in the story here, huge rewards for the patient. Gotta love that $70 prudential 12-month target. Looks like stock is getting beaten down with that last CNCT sale. Once that is done, a quick leap back to 30 looks probable. Very very very few biotechs in this world have a product with potential sales of 4+ billion, is already approved for some indications, and is in human trials for the remaining indications. The potential here easily dwarfs IMCL, which has a current cap of almost 2 billion. SM

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next